tiprankstipranks
Adlai Nortye Ltd. Sponsored ADR (ANL)
NASDAQ:ANL
US Market
Want to see ANL full AI Analyst Report?

Adlai Nortye Ltd. Sponsored ADR (ANL) Blogger Opinions & Sentiment

78 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
ANL Blogger sentiment is based on 3 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
66% Investing
34% Zacks
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Wall Street Analysts See an 81.78% Upside in Adlai Nortye Ltd. Sponsored ADR (ANL) Can the Stock Really Move This High
Zacks
Adlai Nortye expands scientific advisory board with two oncologists
Investing
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of ANL?
Currently there's no blogger sentiment for ANL.
What do Motley Fool contributors think of ANL?
Currently there's no blogger sentiment for ANL.
What Is ANL’s Blogger Sentiment?
ANL’s Blogger Sentiment is Bullish.
    What was the most recent blogger prediction for ANL?
    The most recent blogger prediction for ANL was made by NASDAQ:ANL, who was Bullish on the stock.
      How can I follow the stock ratings of top Top Financial Bloggers?
      Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Stocks with the Highest Top Blogger Ratings in the Healthcare sector
        KURAKura Oncology
        IOVAIovance Biotherapeutics
        DFTXDefinium Therapeutics
        TRLVTrulieve Cannabis
        VKTXViking Therapeutics